Tucatinib is an anticancer medication used for the treatment of HER2-positive breast cancer. It is a…
HANQUYOU® (Trastuzumab) sold under the brand name 汉曲优® in china, Since its launch, 汉曲优® has been…
Ivosidenib is a first-in-class isocitrate dehydrogenase-1 (IDH1) inhibitor. Ivosidenib is an anti-cancer medication for the treatment of acute…
Tevimbra (Tislelizumab-jsgr) sold under the brand name 百泽安 in china, is a humanized IgG4 anti–PD-1 monoclonal…
Zerpidio (Serplulimab) sold under the brand name 汉斯状 in china. Serplulimab, a recombinant humanised anti-PD-1 monoclonal…
BRUKINSA (Zanubrutinib) sold under the brand name 百悦泽 in china, is a BTK Inhibitor used to…
Fruquintinib (Fruzaqla) sold under the brand name 爱优特 in china, is an oral, highly selective, small molecule…
Loqtorzi (toripalimab-tpzi) sold under the brand name 拓益 in china, is a next generation anti-PD-1 monoclonal antibody…
Avzivi® (Bevacizumab-tnjn) sold under the brand name POBEVCY (普贝希) in China, is a humanized monoclonal antibody…
Enasidenib is a medication used to treat relapsed or refractory acute myeloid leukemia (AML) in people with specific mutations…
Enasidenib is a medication used to treat relapsed or refractory acute myeloid leukemia (AML) in people with specific…
Larotrectinib is a treatment for solid cancers that have a neurotrophic tyrosine receptor kinase (NTRK) gene change.…
The targeted drug selpercatinib has been a treatment option for some people with lung cancer or…
Non-small Cell Lung Cancer Indicated for metastatic non-small cell lung cancer (NSCLC) in adults whose tumors…
Pemigatinib is a type of targeted cancer drug. It is a treatment for bile duct cancer that…
Cabozantinib is an anti-cancer medication used to treat medullary thyroid cancer, renal cell carcinoma, and hepatocellular…